Business
Company update on activities
Company update on activities.
About this update from Optibiotix Health Plc
[{"type":"text","content":"\n\n \nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\")\n29 July 2024\nCompany update on activities\n \nOptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, cardiovascular disease, diabetes and skincare, provides an update on Company activities and current outlook.\n \nOptiBiotix's products have been developed to meet the needs of global megatrends. Given the long development timeline for new products with clinical studies and the difficulties of predicting future trends, OptiBiotix developed a broad portfolio of products to mitigate risks. However, a number of recent market reports suggest that products across all of OptiBiotix's portfolio have potential to meet growing market trends as highlighted in the links below:-\n \na. Proven Scientific and clinically efficacy is a key consumer requirement in purchasing health products The top wellness trends in 2024 | McKinsey\nb. Natural weight management/appetite suppressants like SlimBiome® https://www.verifiedmarketreports.com/product/appetite-suppressants-market/\nc. Digestive Health and the Microbiome (WellBiome®, Microbiome modulators) - Ten Key Health and Nutrition Trends for 2024 - KHNI (kerry.com)\nd. Sugar reduction (SweetBiotix® Ten Key Health and Nutrition Trends for 2024 - KHNI (kerry.com)\n \nThe recent article in the Daily Mail MIDAS column, available here, highlights the potential for SlimBiome® as a natural alternative to the blockbuster weight loss drugs that are currently on the market and how the launch of these drugs has increased interest in natural products like SlimBiome® which help users lose weight by suppressing their appetite. Media interest has helped OptiBiotix secure a number of interviews with journalists and an article in the August issue of Nutrition Industry Executive (NIE), a publication widely read by industry decision-makers in the USA. \n \nOptiBiotix has been raising awareness of the potential for its clinically proven product, SlimBiome®, which works in a similar way to Ozempic/Wegovy to reduce hunger and cravings to support weight loss in overweight individuals. OptiBiotix's commercial focus has been on overweight individuals, but recent work with dietici...